Daniel A. Hamstra, MD, PhD, FASTRO, FASCO, presented “The Role of Radiotherapy in Oligometastatic Prostate Cancer and How to Treat the Primary in De Novo Oligometastatic Disease” at the 27th Annual Innovations in Urologic Practice conference on September 22nd, 2023.
How to cite: Hamstra, Daniel A. “The Role of Radiotherapy in Oligometastatic Prostate Cancer and How to Treat the Primary in De Novo Oligometastatic Disease.” September 2023. Accessed Nov 2024. https://grandroundsinurology.com/the-role-of-radiotherapy-in-oligometastatic-prostate-cancer-and-how-to-treat-the-primary-in-de-novo-oligometastatic-disease/
The Role of Radiotherapy in Oligometastatic Prostate Cancer and How to Treat the Primary in De Novo Oligometastatic Disease – Summary
Daniel A. Hamstra, MD, PhD, FASTRO, FASCO, discusses the use of radiotherapy in oligometastatic prostate cancer treatment and how to approach treating the primary in de novo oligometastatic disease. In this presentation, Dr. Hamstra covers:
- The history and definition of oligometastatic disease.
- The history of radiation therapy in localized and metastatic prostate cancer.
- Results from the STAMPEDE, PEACE-1, and STOMP and ORIOLE trials.
- The Pros and Cons of including radiation therapy in systemic therapy.
- Progression to Survival and Overall Survival rates in radiation therapy patients.
Dr. Hamstra concludes by highlighting the need for more data on low-volume versus high-volume oligometastatic patients, and he recommends enrolling eligible patients in the ongoing SWOG S1802 trial.
About The 27th Annual Innovations in Urologic Practice:
Presented by co-chairs Mohit Khera, MD, MBA, MPH, and Michael Coburn, MD, FACS, the Innovations in Urologic Practice conference provides a detailed review and commentary on multiple genitourinary and urologic diseases. Among the featured oncological topics are bladder cancer and immunotherapies, as well as upper tract cancer management, prostate cancer, including state-of-the-art imaging, focal therapy, and MRI. Experts also discuss new tools and techniques for nephrectomy and treating advanced renal cell carcinoma. In terms of general urological approaches, the conference also includes pelvic reconstruction and trauma; men’s health topics like male infertility, andrology, and sexual dysfunction; OAB and voiding dysfunctions; and ways to diagnose and treat infections in the urology patient.
For further educational activities from this conference, visit our collection page.
ABOUT THE AUTHOR
Daniel A. Hamstra, MD, PhD, FASTRO, FASCO, is Professor and Chair of Radiation Oncology at Baylor College of Medicine in Houston, Texas. Dr. Hamstra specializes in prostate cancer and tumors of the brain and spine with a particular focus on understanding patients’ experience both during and after treatment. His work has made a substantial impact on the growing understanding and appreciation of patient reported quality of life after radiation therapy. He has led local and national clinical trials of radiation therapy in prostate cancer and is an active member of several medical professional societies including the American Society of Clinical Oncology, the American Society of Therapeutic Radiation Oncology, and SWOG.
